These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

415 related items for PubMed ID: 14603504

  • 1. Pharmacokinetics of DA-8159, a new erectogenic, after intravenous and oral administration to rats: hepatic and intestinal first-pass effects.
    Shim HJ, Kim YC, Park KJ, Kim DS, Kwon JW, Kim WB, Lee MG.
    J Pharm Sci; 2003 Nov; 92(11):2185-95. PubMed ID: 14603504
    [Abstract] [Full Text] [Related]

  • 2. Dose-independent pharmacokinetics of a new neuroprotective agent for ischemia-reperfusion damage, KR-31543, after intravenous and oral administration to rats: hepatic and intestinal first-pass effects.
    Lee MH, Bae SK, Kim EJ, Kim YG, Kim SO, Lee DH, Lim H, Yoo SE, Lee MG.
    J Pharm Sci; 2003 Jan; 92(1):190-201. PubMed ID: 12486695
    [Abstract] [Full Text] [Related]

  • 3. Dose-independent pharmacokinetics of a candidate for diabetic neuropathy, SR-4668, after intravenous and oral administration to rats: Intestinal first-pass effect.
    Kim EJ, Bae SK, Kim HJ, Kim YG, Kim SO, Lee DH, Lim H, Lee MG.
    J Pharm Sci; 2003 May; 92(5):1112-24. PubMed ID: 12712431
    [Abstract] [Full Text] [Related]

  • 4. Pharmacokinetics of sildenafil after intravenous and oral administration in rats: hepatic and intestinal first-pass effects.
    Shin HS, Bae SK, Lee MG.
    Int J Pharm; 2006 Aug 31; 320(1-2):64-70. PubMed ID: 16730145
    [Abstract] [Full Text] [Related]

  • 5. Hepatic and intestinal first-pass effects of oltipraz in rats.
    Bae SK, Kim JW, Kim YH, Kim YG, Kim SG, Lee MG.
    Biopharm Drug Dispos; 2005 May 31; 26(4):129-34. PubMed ID: 15744718
    [Abstract] [Full Text] [Related]

  • 6. Dose-independent pharmacokinetics of metformin in rats: Hepatic and gastrointestinal first-pass effects.
    Choi YH, Kim SG, Lee MG.
    J Pharm Sci; 2006 Nov 31; 95(11):2543-52. PubMed ID: 16937336
    [Abstract] [Full Text] [Related]

  • 7. Pharmacokinetics of ipriflavone, an isoflavone derivative, after intravenous and oral administration to rats hepatic and intestinal first-pass effects.
    Kim SH, Lee MG.
    Life Sci; 2002 Feb 01; 70(11):1299-315. PubMed ID: 11883708
    [Abstract] [Full Text] [Related]

  • 8. Pharmacokinetics of a chemoprotective agent, 2-(allylthio)pyrazine, after intravenous and oral administration to rats: hepatic and gastric first-pass effects.
    Han KS, Lee MG.
    Drug Metab Dispos; 1999 Feb 01; 27(2):221-6. PubMed ID: 9929506
    [Abstract] [Full Text] [Related]

  • 9. Dose-independent pharmacokinetics of a new reversible proton pump inhibitor, KR-60436, after intravenous and oral administration to rats: gastrointestinal first-pass effect.
    Yu SY, Bae SK, Kim EJ, Kim YG, Kim SO, Lee DH, Lim H, Lee MG.
    J Pharm Sci; 2003 Aug 01; 92(8):1592-603. PubMed ID: 12884246
    [Abstract] [Full Text] [Related]

  • 10. Pharmacokinetic interaction between 5-[2-propyloxy-5-(1-methyl-2-pyrollidinylethylamidosulfonyl)phenyl]-1-methyl-3-propyl-1,6-dihydro-7H-pyrazolo (4,3-d) pyrimidine-7-one (DA-8159) and nitroglycerin in rats.
    Lee SJ, Bae SK, Kwon JW, You M, Lee DC, Lee MG.
    J Pharm Pharmacol; 2005 Nov 01; 57(11):1397-405. PubMed ID: 16259771
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Gastrointestinal first-pass effect of YJA-20379-8, a new reversible proton pump inhibitor, in rats.
    Kim J, Kim EJ, Han KS, Chang MS, Lee MG.
    J Pharm Pharmacol; 1999 Sep 01; 51(9):1031-6. PubMed ID: 10528986
    [Abstract] [Full Text] [Related]

  • 14. Dose-dependent pharmacokinetics of itraconazole after intravenous or oral administration to rats: intestinal first-pass effect.
    Shin JH, Choi KY, Kim YC, Lee MG.
    Antimicrob Agents Chemother; 2004 May 01; 48(5):1756-62. PubMed ID: 15105131
    [Abstract] [Full Text] [Related]

  • 15. Dose-dependent pharmacokinetics and first-pass effects of mirodenafil, a new erectogenic, in rats.
    Choi YH, Lee YS, Bae SH, Kim TK, Lee BY, Lee MG.
    Biopharm Drug Dispos; 2009 Sep 01; 30(6):305-17. PubMed ID: 19639551
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Species differences in the formation of DA-8164 after intravenous and/or oral administration of DA-8159, a new erectogenic, to mice, rats, rabbits, dogs and humans.
    Shim HJ, Kim YC, Lee JH, Park KJ, Kwon JW, Kim WB, Lee MG.
    Biopharm Drug Dispos; 2005 May 01; 26(4):161-6. PubMed ID: 15803515
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Dose-independent pharmacokinetics of ondansetron in rats: contribution of hepatic and intestinal first-pass effects to low bioavailability.
    Yang SH, Lee MG.
    Biopharm Drug Dispos; 2008 Oct 01; 29(7):414-26. PubMed ID: 18697186
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.